ICU Medical, Inc. (ICUI)

NASDAQ: ICUI · IEX Real-Time Price · USD
+0.19 (0.16%)
Sep 28, 2023, 10:20 AM EDT - Market open

Company Description

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide.

Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters.

The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options.

It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems.

The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities.

ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

ICU Medical, Inc.
ICU Medical logo
Country United States
Founded 1984
IPO Date Mar 31, 1992
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 14,500
CEO Vivek Jain

Contact Details

951 Calle Amanecer
San Clemente, California 92763-6212
United States
Phone 949-366-2183

Stock Details

Ticker Symbol ICUI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000883984
CUSIP Number 44930G107
ISIN Number US44930G1076
Employer ID 33-0022692
SIC Code 3841

Key Executives

Name Position
Vivek Jain Chief Executive Officer and Chairman
Brian Michael Bonnell Chief Financial Officer and Treasurer
Christian B. Voigtlander Chief Operating Officer
Virginia Ruth Sanzone Corporate Vice President, General Counsel, Secretary and Compliance Officer

Latest SEC Filings

Date Type Title
Sep 8, 2023 144 Filing
Aug 7, 2023 10-Q Quarterly Report
Aug 7, 2023 8-K Current Report
Jul 12, 2023 144 Filing
Jun 14, 2023 144 Filing
May 31, 2023 SD Form - SD
May 22, 2023 8-K Current Report
May 9, 2023 10-Q Quarterly Report
May 8, 2023 8-K Current Report
Apr 11, 2023 144 Filing